Bone morphogenetic protein 10 alleviates doxorubicin-induced cardiac injury via signal transducer and activator of transcription 3 signaling pathway

References

• Goncalves M, Mignani S, Rodrigues J, et al. A glance over doxorubicin based-nanotherapeutics: from proof-of-concept studies to solutions in the market. J Control Release. 2020;317:347–374.
   PubMed Web of Science ®Google Scholar
• Li M, Sala V, De Santis MC, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth. Circulation. 2018;138(7):696–711.
   PubMed Web of Science ®Google Scholar
• Zhang J,Xiao, M., Wang, S., Guo, Y., Tang, Y., and Gu, J. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways. Cell Mol Life Sci. 2021;78(7):1–21.
   Web of Science ®Google Scholar
• Bartlett JJ, Trivedi PC, Pulinilkunnil T. Autophagic dysregulation in doxorubicin cardiomyopathy. J Mol Cell Cardiol. 2017;104:1–8.
   PubMed Web of Science ®Google Scholar
• Sabatino J, De Rosa, S., Tammè, L., Iaconetti, C., Sorrentino, S., Polimeni, A., Mignogna, C., Amorosi, A., Spaccarotella, C., Yasuda, M. and Indolfi, C. Empagliflozin prevents doxorubicin-induced myocardial dysfunction. Cardiovasc Diabetol. 2020;19:1–11.
   PubMed Web of Science ®Google Scholar
• Force T, and Wang Y. Mechanism-based engineering against anthracycline cardiotoxicity. Am Heart Assoc. 2013;128(2):98–100.
   Google Scholar
• Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18(11):1639–1642.
   PubMed Web of Science ®Google Scholar
• Wang F, Han L. Upregulation of serum and glucocorticoid-regulated kinase 1 (SGK1) ameliorates doxorubicin-induced cardiotoxic injury, apoptosis, inflammation and oxidative stress by suppressing glucose regulated protein 78 (GRP78)-mediated endoplasmic reticulum stress. Bioengineered. 2022;13(1):844–855.
   PubMed Web of Science ®Google Scholar
• Songbo M, Lang H, Xinyong C, et al. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. 2019;307:41–48.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang H, Xu D, et al. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway. Bioengineered. 2022;13(1):48–60.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–762.
   PubMed Web of Science ®Google Scholar
• Zhao L, Qi Y, Xu L, et al. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol. 2018;15:284–296.
   PubMed Web of Science ®Google Scholar
• Levis BE, Binkley PF, Shapiro CL. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol. 2017;18(8):e445–e456.
   PubMed Web of Science ®Google Scholar
• You L, Wang Z, Li H, et al. The role of STAT3 in autophagy. Autophagy. 2015;11(5):729–739.
   PubMed Web of Science ®Google Scholar
• Ye S, Luo W, Khan ZA, et al. Celastrol attenuates angiotensin II–induced cardiac remodeling by targeting STAT3. Circ Res. 2020;126(8):1007–1023.
   PubMed Web of Science ®Google Scholar
• O’Sullivan K, Breen EP, Gallagher HC, et al. Understanding STAT3 signaling in cardiac ischemia. Basic Res Cardiol. 2016;111(3):27.
   PubMed Web of Science ®Google Scholar
• Yu S, Guo H, Luo Y, et al. Ozone protects cardiomyocytes against ischemia/reperfusion injury: regulating the heat shock protein 70 (HSP70) expression through activating the JAK2/STAT3 Pathway. Bioengineered. 2021;12(1):6606–6616.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhou J, Xu C, et al. JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem. 2008;21(4):305–314.
   PubMedGoogle Scholar
• Szczepanek K, Chen Q, Derecka M, et al. Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem. 2011;286(34):29610–29620.
   PubMed Web of Science ®Google Scholar
• Wu J, Guo W, Lin S-Z, et al. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity. Cell Death Dis. 2016;7(8):e2339–e2339.
   PubMedGoogle Scholar
• Kunisada K, Negoro S, Tone E, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Nat Acad Sci. 2000;97(1):315–319.
   PubMed Web of Science ®Google Scholar
• Yuan Y-M, Ma N, Zhang E-B, et al. BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis. Oncogene. 2019;38(48):7281–7293.
   PubMed Web of Science ®Google Scholar
• Mikryukov AA, Mazine A, Wei B, et al. BMP10 signaling promotes the development of endocardial cells from human pluripotent stem cell-derived cardiovascular progenitors. Cell Stem Cell. 2021;28(1):96–111e7.
   PubMed Web of Science ®Google Scholar
• Chen H, Brady Ridgway J, Sai T, et al. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Nat Acad Sci. 2013;110(29):11887–11892.
   PubMed Web of Science ®Google Scholar
• Neuhaus H, Rosen V, Thies RS. Heart specific expression of mouse BMP-10 a novel member of the TGF-β superfamily. Mech Dev. 1999;80(2):181–184.
   PubMed Web of Science ®Google Scholar
• Owen NE, Alexander GJ, Sen S, et al. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis. EBioMedicine. 2020;56:102794.
   PubMed Web of Science ®Google Scholar
• Nakano N, Hori H, Abe M, et al. Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2007;293(6):H3396–H3403.
   PubMed Web of Science ®Google Scholar
• Huang J, Elicker J, Bowens N, et al. Myocardin regulates BMP10 expression and is required for heart development. J Clin Invest. 2012;122(10):3678–3691.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Da Q, Cao S, et al. Histidine triad nucleotide binding protein 1 attenuates cardiac hypertrophy via suppressing homeobox A5 expression. Circulation. 2021;144(8):638–654.
   PubMed Web of Science ®Google Scholar
• Yuan Y-P, Ma Z-G, Zhang X, et al. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2018;114:38–47.
   PubMed Web of Science ®Google Scholar
• Jacoby JJ, Kalinowski A, Liu M-G, et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Nat Acad Sci. 2003;100(22):12929–12934.
   PubMed Web of Science ®Google Scholar
• Ma Z-G, Yuan Y-P, Zhang X, et al. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovasc Res. 2019;115(6):1067–1077.
   PubMed Web of Science ®Google Scholar
• Ma S-Q,Guo, Z., Liu, F.Y., Hasan, S.G., Yang, D., Tang, N., An, P., Wang, M.Y., Wu, H.M., Yang, Z., and Fan, D. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway. Acta Pharmacol Sin. 2021;42(10):1–12.
   Web of Science ®Google Scholar
• Guo Z, Tang N, Liu F-Y, et al. TLR9 deficiency alleviates doxorubicin‐induced cardiotoxicity via the regulation of autophagy. J Cell Mol Med. 2020;24(18):10913–10923.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu C, Kong C-Y, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020;27(2):540–555.
   PubMed Web of Science ®Google Scholar
• Deng J, Huang M, Wu H. Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor-like 2 and Sirtuin 2 signaling pathways. Bioengineered. 2021;12(1):7975–7984.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhang X, Zhang N, et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin‐induced cardiotoxicity. Clin Transl Med. 2020;10(3):e124.
   PubMed Web of Science ®Google Scholar
• Ma Z-G, Kong C-Y, Wu H-M, et al. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020;10(24):11013.
   PubMed Web of Science ®Google Scholar
• Ernst M, Najdovska M, Grail D, et al. STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. 2008;118(5):1727–1738.
   PubMed Web of Science ®Google Scholar
• Damiani RM, Moura DJ, Viau CM, et al. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone. Toxicol in vitro. 2018;52:203–213.
   PubMed Web of Science ®Google Scholar
• Yao M, Ma X, Zhang X, et al. Lectin-mediated pH-sensitive doxorubicin prodrug for pre-targeted chemotherapy of colorectal cancer with enhanced efficacy and reduced side effects. Theranostics. 2019;9(3):747.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Nat Acad Sci. 2019;116(7):2672–2680.
   PubMed Web of Science ®Google Scholar
• Rochette L, Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y. and Vergely, C. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. Trends Pharmacol Sci. 2015;36(6):326–348.
   PubMed Web of Science ®Google Scholar
• Wang L, Rice M, Swist S, et al. BMP9 and BMP10 act directly on vascular smooth muscle cells for generation and maintenance of the contractile state. Circulation. 2021;143(14):1394–1410.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Cui Y, Christian J. Regulation of BMP/Dpp signaling during embryonic development. Cell Mol Life Sci. 2000;57(6):943–956.
   PubMed Web of Science ®Google Scholar
• Han L, Liu H, Fu H, et al. Exosome-delivered BMP-2 and polyaspartic acid promotes tendon bone healing in rotator cuff tear via Smad/RUNX2 signaling pathway. Bioengineered. 2022;13(1):1459–1475.
   PubMed Web of Science ®Google Scholar
• Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000;57(6):2207–2214.
   PubMed Web of Science ®Google Scholar
• Schneider MD, Gaussin V, Lyons KM. Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev. 2003;14(1):1–4.
   PubMed Web of Science ®Google Scholar
• Chen H, Shi S, Acosta L, et al. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development. 2004;131(9):2219–2231.
   PubMed Web of Science ®Google Scholar
• Li W, Salmon, R.M., Jiang, H. and Morrell, N.W. Regulation of the ALK1 ligands, BMP9 and BMP10. Biochem Soc Trans. 2016;44(4):1135–1141.
   PubMedGoogle Scholar
• Qu X, Liu Y, Cao D, et al. BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways. J Biol Chem. 2019;294(52):19877–19888.
   PubMed Web of Science ®Google Scholar
• Yun MR, Park HM, Seo KW, et al. 5-Lipoxygenase plays an essential role in 4-HNE-enhanced ROS production in murine macrophages via activation of NADPH oxidase. Free Radic Res. 2010;44(7):742–750.
   PubMed Web of Science ®Google Scholar
• Noh J, Kwon B, Han E, et al. Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death. Nat Commun. 2015;6(1):1–9.
   Google Scholar
• Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak–STAT signaling in the immune system. Nat Immunol. 2017;18(4):374–384.
   PubMed Web of Science ®Google Scholar
• Laudisi F, Cherubini F, Monteleone G, et al. STAT3 interactors as potential therapeutic targets for cancer treatment. Int J Mol Sci. 2018;19(6):1787.
   PubMed Web of Science ®Google Scholar
• Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798–809.
   PubMed Web of Science ®Google Scholar
• Pan M, Yin X, Huang Y-C. Pseudopodium enriched atypical kinase 1 (PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals. Bioengineered. 2021;12(1):5045–5055.
   PubMed Web of Science ®Google Scholar
• Lee T-M, Chang N-C, Lin S-Z. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic Biol Med. 2017;104:298–310.
   PubMed Web of Science ®Google Scholar
• Lemoine S, Zhu L, Legallois D, et al. Atorvastatin-induced cardioprotection of human myocardium is mediated by the inhibition of mitochondrial permeability transition pore opening via tumor necrosis factor-α and Janus kinase/signal transducers and activators of transcription pathway. Anesthesiology. 2013;118(6):1373–1384.
   PubMed Web of Science ®Google Scholar
• Busker S, Qian, W., Haraldsson, M., Espinosa, B., Johansson, L., Attarha, S., Kolosenko, I., Liu, J., Dagnell, M., Grander, D. and Arner, E.S.J. Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death. Sci Adv. 2020;6(12):eaax7945.
   PubMed Web of Science ®Google Scholar